KATHE HEFNER-ERICKSON: Open Payments
NPI 1366626301 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 27 payments from 12 companies in 2025. Trend: 2023 $646 · 2024 $730 · 2025 $873
Food & beverage: $723Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 3 | $220 |
| Axsome Therapeutics, Inc. | 8 | $215 |
| HARMONY BIOSCIENCES LLC | 6 | $203 |
| Lilly USA, LLC | 2 | $42 |
| PFIZER INC. | 1 | $32 |
| GENZYME CORPORATION | 1 | $31 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $28 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Abbott Laboratories | 1 | $18 |
Products named: XYWAV, Sunosi, WAKIX, OCTAGAM IMMUNE GLOBULIN (HUMAN), DUPIXENT, LUMRYZ, PURIFIED CORTROPHIN GEL, FASENRA.
Industry payments across DE — which companies pay providers there.
